1. Home
  2. ENOV vs PGNY Comparison

ENOV vs PGNY Comparison

Compare ENOV & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • PGNY
  • Stock Information
  • Founded
  • ENOV 1995
  • PGNY 2008
  • Country
  • ENOV United States
  • PGNY United States
  • Employees
  • ENOV N/A
  • PGNY N/A
  • Industry
  • ENOV Fluid Controls
  • PGNY Misc Health and Biotechnology Services
  • Sector
  • ENOV Industrials
  • PGNY Health Care
  • Exchange
  • ENOV Nasdaq
  • PGNY Nasdaq
  • Market Cap
  • ENOV 2.1B
  • PGNY 1.9B
  • IPO Year
  • ENOV 2008
  • PGNY 2019
  • Fundamental
  • Price
  • ENOV $32.35
  • PGNY $22.31
  • Analyst Decision
  • ENOV Buy
  • PGNY Buy
  • Analyst Count
  • ENOV 4
  • PGNY 9
  • Target Price
  • ENOV $58.50
  • PGNY $22.71
  • AVG Volume (30 Days)
  • ENOV 837.4K
  • PGNY 1.7M
  • Earning Date
  • ENOV 05-01-2025
  • PGNY 05-08-2025
  • Dividend Yield
  • ENOV N/A
  • PGNY N/A
  • EPS Growth
  • ENOV N/A
  • PGNY N/A
  • EPS
  • ENOV N/A
  • PGNY 0.57
  • Revenue
  • ENOV $2,107,623,000.00
  • PGNY $1,167,221,000.00
  • Revenue This Year
  • ENOV $7.09
  • PGNY $5.38
  • Revenue Next Year
  • ENOV $6.38
  • PGNY $11.30
  • P/E Ratio
  • ENOV N/A
  • PGNY $40.61
  • Revenue Growth
  • ENOV 23.45
  • PGNY 7.22
  • 52 Week Low
  • ENOV $33.73
  • PGNY $13.39
  • 52 Week High
  • ENOV $62.79
  • PGNY $36.51
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 25.13
  • PGNY 55.65
  • Support Level
  • ENOV $36.43
  • PGNY $21.99
  • Resistance Level
  • ENOV $38.56
  • PGNY $23.26
  • Average True Range (ATR)
  • ENOV 1.39
  • PGNY 0.70
  • MACD
  • ENOV -0.42
  • PGNY 0.16
  • Stochastic Oscillator
  • ENOV 5.98
  • PGNY 72.46

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About PGNY Progyny Inc.

Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.

Share on Social Networks: